World Health Organization Aims To Roll Out 120 Million COVID-19 Rapid Tests in Lower Income Countries – As COVID-19 Deaths Cross The 1 Million Mark 28/09/2020 Grace Ren Some 120 million COVID-19 rapid diagnostic tests will be made available to low and middle-income countries through the World Health Organization-hosted ACT Accelerator, an initiative to scale up COVID-19 drugs, diagnostics, and vaccines. The WHO Director-General Dr Tedros Adhanom Ghebreyesus made the announcement just before the world crossed the 1 million mark for deaths from […] Continue reading -> Progress On COVID-19 Technology Pool Inches Along As Sister Initiative To Pool Vaccine Procurement Accelerates 25/09/2020 Grace Ren While the COVAX Facility, a global initiative to pool procurement of a safe and effective COVID-19 vaccine, has been gaining momentum, another global initiative to pool intellectual property rights for tools to combat the pandemic has been moving at a much slower pace. Only three more countries have signed on to support the COVID-19 Technology […] Continue reading -> Global Call For Rebuilding Vaccine Networks In Advance Of COVID-19 Vaccine Rollout 24/09/2020 Raisa Santos A lineup of global health leaders called upon high income countries to join the new global COVID-19 pool, saying that worldwide access to a safe and equitable vaccine is essential to beat the COVID-19 pandemic. Speaking at the virtual UN General Assembly (UNGA) side event on Wednesday, the leaders also said that maintaining essential vaccine […] Continue reading -> US FDA Commissioner Promises Not To Bow To Political Pressure On COVID-19 Vaccine Timetable – President Donald Trump Says Any Delay Would Need White House Approval 23/09/2020 Grace Ren & Elaine Ruth Fletcher United States President Donald Trump told a press conference that any moves by the Food and Drug Administration (FDA) to delay emergency authorization of any forthcoming COVID-19 vaccine for an additional two months to ensure safety concerns are met, “sounds like a political move more than everything else” and such a delay “has to be […] Continue reading -> US Health Secretary Will Now Sign Off On New Rules Passed By The US Food & Drug Administration 22/09/2020 Grace Ren The United States Food and Drug Administration on Tuesday proposed a new rule regarding regulation of medical products that would be the first in the agency’s history to also require the signature of United States Health and Human Services (HHS) Secretary, before it can be formally adopted. As such it will likely be a test […] Continue reading -> 64 High-Income Countries Make Binding Commitments To Buy COVID-19 Vaccines From New Global Facility – Billions Of Dollars Needed For Low-Income Nations 21/09/2020 Grace Ren Some 64 higher income countries have now made binding financial commitments to a precedent-setting COVID-19 global vaccine pool that aims to equitably distribute future vaccines to halt the pandemic raging now. Another 38 countries are expected to commit over the next week, said CEO Berkley, in a WHO press conference Monday that disclosed the landmark […] Continue reading -> Africa Lagging In COVID-19 Clinical Trials As Global Studies Cross 1000 Mark 18/09/2020 Maina Waruru Nairobi, Kenya – Africa is trailing the rest of the world in conducting clinical studies on COVID-19 vaccines and drugs. Less than 70 registered studies for drugs and vaccines are currently taking place in Africa, out of more than 1000 studies being conducted globally. Only 8 of 102 clinical vaccine trials were being conducted in […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Progress On COVID-19 Technology Pool Inches Along As Sister Initiative To Pool Vaccine Procurement Accelerates 25/09/2020 Grace Ren While the COVAX Facility, a global initiative to pool procurement of a safe and effective COVID-19 vaccine, has been gaining momentum, another global initiative to pool intellectual property rights for tools to combat the pandemic has been moving at a much slower pace. Only three more countries have signed on to support the COVID-19 Technology […] Continue reading -> Global Call For Rebuilding Vaccine Networks In Advance Of COVID-19 Vaccine Rollout 24/09/2020 Raisa Santos A lineup of global health leaders called upon high income countries to join the new global COVID-19 pool, saying that worldwide access to a safe and equitable vaccine is essential to beat the COVID-19 pandemic. Speaking at the virtual UN General Assembly (UNGA) side event on Wednesday, the leaders also said that maintaining essential vaccine […] Continue reading -> US FDA Commissioner Promises Not To Bow To Political Pressure On COVID-19 Vaccine Timetable – President Donald Trump Says Any Delay Would Need White House Approval 23/09/2020 Grace Ren & Elaine Ruth Fletcher United States President Donald Trump told a press conference that any moves by the Food and Drug Administration (FDA) to delay emergency authorization of any forthcoming COVID-19 vaccine for an additional two months to ensure safety concerns are met, “sounds like a political move more than everything else” and such a delay “has to be […] Continue reading -> US Health Secretary Will Now Sign Off On New Rules Passed By The US Food & Drug Administration 22/09/2020 Grace Ren The United States Food and Drug Administration on Tuesday proposed a new rule regarding regulation of medical products that would be the first in the agency’s history to also require the signature of United States Health and Human Services (HHS) Secretary, before it can be formally adopted. As such it will likely be a test […] Continue reading -> 64 High-Income Countries Make Binding Commitments To Buy COVID-19 Vaccines From New Global Facility – Billions Of Dollars Needed For Low-Income Nations 21/09/2020 Grace Ren Some 64 higher income countries have now made binding financial commitments to a precedent-setting COVID-19 global vaccine pool that aims to equitably distribute future vaccines to halt the pandemic raging now. Another 38 countries are expected to commit over the next week, said CEO Berkley, in a WHO press conference Monday that disclosed the landmark […] Continue reading -> Africa Lagging In COVID-19 Clinical Trials As Global Studies Cross 1000 Mark 18/09/2020 Maina Waruru Nairobi, Kenya – Africa is trailing the rest of the world in conducting clinical studies on COVID-19 vaccines and drugs. Less than 70 registered studies for drugs and vaccines are currently taking place in Africa, out of more than 1000 studies being conducted globally. Only 8 of 102 clinical vaccine trials were being conducted in […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Call For Rebuilding Vaccine Networks In Advance Of COVID-19 Vaccine Rollout 24/09/2020 Raisa Santos A lineup of global health leaders called upon high income countries to join the new global COVID-19 pool, saying that worldwide access to a safe and equitable vaccine is essential to beat the COVID-19 pandemic. Speaking at the virtual UN General Assembly (UNGA) side event on Wednesday, the leaders also said that maintaining essential vaccine […] Continue reading -> US FDA Commissioner Promises Not To Bow To Political Pressure On COVID-19 Vaccine Timetable – President Donald Trump Says Any Delay Would Need White House Approval 23/09/2020 Grace Ren & Elaine Ruth Fletcher United States President Donald Trump told a press conference that any moves by the Food and Drug Administration (FDA) to delay emergency authorization of any forthcoming COVID-19 vaccine for an additional two months to ensure safety concerns are met, “sounds like a political move more than everything else” and such a delay “has to be […] Continue reading -> US Health Secretary Will Now Sign Off On New Rules Passed By The US Food & Drug Administration 22/09/2020 Grace Ren The United States Food and Drug Administration on Tuesday proposed a new rule regarding regulation of medical products that would be the first in the agency’s history to also require the signature of United States Health and Human Services (HHS) Secretary, before it can be formally adopted. As such it will likely be a test […] Continue reading -> 64 High-Income Countries Make Binding Commitments To Buy COVID-19 Vaccines From New Global Facility – Billions Of Dollars Needed For Low-Income Nations 21/09/2020 Grace Ren Some 64 higher income countries have now made binding financial commitments to a precedent-setting COVID-19 global vaccine pool that aims to equitably distribute future vaccines to halt the pandemic raging now. Another 38 countries are expected to commit over the next week, said CEO Berkley, in a WHO press conference Monday that disclosed the landmark […] Continue reading -> Africa Lagging In COVID-19 Clinical Trials As Global Studies Cross 1000 Mark 18/09/2020 Maina Waruru Nairobi, Kenya – Africa is trailing the rest of the world in conducting clinical studies on COVID-19 vaccines and drugs. Less than 70 registered studies for drugs and vaccines are currently taking place in Africa, out of more than 1000 studies being conducted globally. Only 8 of 102 clinical vaccine trials were being conducted in […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US FDA Commissioner Promises Not To Bow To Political Pressure On COVID-19 Vaccine Timetable – President Donald Trump Says Any Delay Would Need White House Approval 23/09/2020 Grace Ren & Elaine Ruth Fletcher United States President Donald Trump told a press conference that any moves by the Food and Drug Administration (FDA) to delay emergency authorization of any forthcoming COVID-19 vaccine for an additional two months to ensure safety concerns are met, “sounds like a political move more than everything else” and such a delay “has to be […] Continue reading -> US Health Secretary Will Now Sign Off On New Rules Passed By The US Food & Drug Administration 22/09/2020 Grace Ren The United States Food and Drug Administration on Tuesday proposed a new rule regarding regulation of medical products that would be the first in the agency’s history to also require the signature of United States Health and Human Services (HHS) Secretary, before it can be formally adopted. As such it will likely be a test […] Continue reading -> 64 High-Income Countries Make Binding Commitments To Buy COVID-19 Vaccines From New Global Facility – Billions Of Dollars Needed For Low-Income Nations 21/09/2020 Grace Ren Some 64 higher income countries have now made binding financial commitments to a precedent-setting COVID-19 global vaccine pool that aims to equitably distribute future vaccines to halt the pandemic raging now. Another 38 countries are expected to commit over the next week, said CEO Berkley, in a WHO press conference Monday that disclosed the landmark […] Continue reading -> Africa Lagging In COVID-19 Clinical Trials As Global Studies Cross 1000 Mark 18/09/2020 Maina Waruru Nairobi, Kenya – Africa is trailing the rest of the world in conducting clinical studies on COVID-19 vaccines and drugs. Less than 70 registered studies for drugs and vaccines are currently taking place in Africa, out of more than 1000 studies being conducted globally. Only 8 of 102 clinical vaccine trials were being conducted in […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Health Secretary Will Now Sign Off On New Rules Passed By The US Food & Drug Administration 22/09/2020 Grace Ren The United States Food and Drug Administration on Tuesday proposed a new rule regarding regulation of medical products that would be the first in the agency’s history to also require the signature of United States Health and Human Services (HHS) Secretary, before it can be formally adopted. As such it will likely be a test […] Continue reading -> 64 High-Income Countries Make Binding Commitments To Buy COVID-19 Vaccines From New Global Facility – Billions Of Dollars Needed For Low-Income Nations 21/09/2020 Grace Ren Some 64 higher income countries have now made binding financial commitments to a precedent-setting COVID-19 global vaccine pool that aims to equitably distribute future vaccines to halt the pandemic raging now. Another 38 countries are expected to commit over the next week, said CEO Berkley, in a WHO press conference Monday that disclosed the landmark […] Continue reading -> Africa Lagging In COVID-19 Clinical Trials As Global Studies Cross 1000 Mark 18/09/2020 Maina Waruru Nairobi, Kenya – Africa is trailing the rest of the world in conducting clinical studies on COVID-19 vaccines and drugs. Less than 70 registered studies for drugs and vaccines are currently taking place in Africa, out of more than 1000 studies being conducted globally. Only 8 of 102 clinical vaccine trials were being conducted in […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
64 High-Income Countries Make Binding Commitments To Buy COVID-19 Vaccines From New Global Facility – Billions Of Dollars Needed For Low-Income Nations 21/09/2020 Grace Ren Some 64 higher income countries have now made binding financial commitments to a precedent-setting COVID-19 global vaccine pool that aims to equitably distribute future vaccines to halt the pandemic raging now. Another 38 countries are expected to commit over the next week, said CEO Berkley, in a WHO press conference Monday that disclosed the landmark […] Continue reading -> Africa Lagging In COVID-19 Clinical Trials As Global Studies Cross 1000 Mark 18/09/2020 Maina Waruru Nairobi, Kenya – Africa is trailing the rest of the world in conducting clinical studies on COVID-19 vaccines and drugs. Less than 70 registered studies for drugs and vaccines are currently taking place in Africa, out of more than 1000 studies being conducted globally. Only 8 of 102 clinical vaccine trials were being conducted in […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Lagging In COVID-19 Clinical Trials As Global Studies Cross 1000 Mark 18/09/2020 Maina Waruru Nairobi, Kenya – Africa is trailing the rest of the world in conducting clinical studies on COVID-19 vaccines and drugs. Less than 70 registered studies for drugs and vaccines are currently taking place in Africa, out of more than 1000 studies being conducted globally. Only 8 of 102 clinical vaccine trials were being conducted in […] Continue reading -> Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna Opens Company’s First Overseas Beachhead In Switzerland 16/09/2020 Elaine Ruth Fletcher Geneva, Switzerland – Moderna, Inc., one of the leaders in the race to develop a new COVID-19 vaccine, has come home — again. The biotech startup, which raised a significant chunk of its initial US$ 100 million amongst a group of far-sighted Swiss investors and private bankers a decade ago, announced Wednesday that it would be establishing […] Continue reading -> AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca COVID-19 Vaccine Trials Resume In the UK After Data Review Board Investigates Safety Signal 14/09/2020 Grace Ren AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> Posts navigation Older postsNewer posts